HitGen Revenue

In the year 2025, HitGen had annual revenue of 525.57M CNY with 23.09% growth. HitGen had revenue of 155.78M in the quarter ending December 31, 2025, with 21.02% growth.

Revenue

525.57M

Revenue Growth

+23.09%

P/S Ratio

20.41

Revenue / Employee

1.09M

Employees

492

Market Cap

10.72B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	525.57M	98.58M	23.09%
Dec 31, 2024	426.99M	55.66M	14.99%
Dec 31, 2023	371.32M	41.67M	12.64%
Dec 31, 2022	329.65M	18.59M	5.98%
Dec 31, 2021	311.06M	67.46M	27.69%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chengzhi	11.53B
China Resources Boya Bio-pharmaceutical Group Co.,Ltd	1.96B
Jiangsu Sinopep-Allsino Biopharmaceutical	1.94B
Liaoning Chengda Biotechnology	1.39B
Aurisco Pharmaceutical	1.62B
Hualan Biological Vaccine	976.44M
Chengdu Olymvax Biopharmaceuticals	704.16M
Chengdu Easton Biopharmaceuticals	1.33B

Revenue Rankings